Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (141-150 of 211) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The limited value of routine chest X-ray in the follow-up of stage II breast cancerV B Løgager, A Vestergaard, J Herrstedt, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Prognostic value of serum tetranectin in patients with metastatic breast cancerC K Høgdall, G Sölétormos, D Nielsen, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lungR A Joss, S Monfardini, M Hansen, et al.
British Journal of Cancer|February 23, 1999
Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progressionU N Lassen, K Osterlind, F R Hirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III studyD Nielsen, P Dombernowsky, T Skovsgaard, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Adjuvant tamoxifen in postmenopausal high-risk breast cancer patients: present status of Danish Breast Cancer Cooperative Group trialsH T Mouridsen, A P Andersen, H Brincker, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Bioavailability of the antiemetic metopimazine given as a microenemaJ Herrstedt, M Jørgensen, H R Angelo, et al.
Journal of Steroid Biochemistry|May 1, 1990
Comparison of the effect of cortisol on aromatase activity and androgen metabolism in two human fibroblast cell lines derived from the same individualB Svenstrup, N Brünner, P Dombernowsky, et al.
British Journal of Cancer|March 10, 1999
Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancerJ B Sørensen, B Bergman, A L Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPAG Sölétormos, D Nielsen, V Schiøler, et al.
Pageof 22

Showing results (141-150 of 211) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The limited value of routine chest X-ray in the follow-up of stage II breast cancerV B Løgager, A Vestergaard, J Herrstedt, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Prognostic value of serum tetranectin in patients with metastatic breast cancerC K Høgdall, G Sölétormos, D Nielsen, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lungR A Joss, S Monfardini, M Hansen, et al.
British Journal of Cancer|February 23, 1999
Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progressionU N Lassen, K Osterlind, F R Hirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III studyD Nielsen, P Dombernowsky, T Skovsgaard, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Adjuvant tamoxifen in postmenopausal high-risk breast cancer patients: present status of Danish Breast Cancer Cooperative Group trialsH T Mouridsen, A P Andersen, H Brincker, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Bioavailability of the antiemetic metopimazine given as a microenemaJ Herrstedt, M Jørgensen, H R Angelo, et al.
Journal of Steroid Biochemistry|May 1, 1990
Comparison of the effect of cortisol on aromatase activity and androgen metabolism in two human fibroblast cell lines derived from the same individualB Svenstrup, N Brünner, P Dombernowsky, et al.
British Journal of Cancer|March 10, 1999
Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancerJ B Sørensen, B Bergman, A L Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPAG Sölétormos, D Nielsen, V Schiøler, et al.
Pageof 22